News & Events

May 17, 2022

Sun Valley throws open its mental health doors

Live the Sun Valley Experience Mental Health Fair held by Sun Valley Medical Center and Sun Valley Research...

March 25, 2022

Breakthrough Treatments for OCD

Detailing Deep TMS as a notable and effective approach for individuals living with medication-resistant...

January 18, 2022

Non-Drug, Non-Invasive, FDA-Cleared Device to Treat OCD

8-minute video interview with BrainsWay President and CEO, Christopher von Jako providing expertise around...

January 13, 2022

We Need a Clearer Understanding of Treatment-Resistant Depression, Experts Say

Dr. Aron Tendler, MD, board-certified psychiatrist and Chief Medical Officer of BrainsWay, shares insights...

December 22, 2021

Transcranial Magnetic Stimulation Shows Promise for Alcohol Addiction

Proof-of-concept research on Deep TMS as a treatment for alcohol dependence, with commentary from Dr....

December 1, 2021

Houston doctors using brain stimulation helmet to treat depression

A behind the curtains look at Deep TMS treatment and how it is currently providing relief for a local...

October 26, 2021

COVID-19 has accelerated the mental health crisis

The importance of mental health is highlighted, with statements from BrainsWay and Chief Medical Officer...

September 20, 2021

MUSC Health among first to offer brain stimulation to try to help smokers quit

Patient testimonials, smoker statistics, and discussion around BrainsWay’s Deep TMS smoking addiction...

September 20, 2021

Mental Health Recap: 4 Must-Read Studies From August 2021

Highlighting the recent FDA clearance for anxious depression with references to the study and a quote...

September 9, 2021

BrainsWay featured on CBS News

Dr. Tendler discusses how emerging technologies, such as BrainsWay’s Deep TMS™, offer hope to...

September 7, 2021

Setting Your Company Up for Success When Navigating Coverage Conversations

BrainsWay CEO and President, Christopher von Jako, PhD discusses the navigation, education, and partner...

August 25, 2021

Transcranial Magnetic Stimulation Device Cleared for Anxious Depression

Summary of the release and research lending to the FDA-clearance of anxious depression, with quotes from...

August 20, 2021

BrainsWay receives FDA clearance for noninvasive comorbid anxiety, depression treatment

Summary of the release, highlighting how this FDA clearance will allow BrainsWay to increase patient...

August 19, 2021

FDA clearance for Deep TMS system in decreasing anxiety symptoms

FDA Clearance for Deep TMS system in decreasing anxiety symptoms in depressed patients, as well as highlights...

August 19, 2021

FDA Clears Deep TMS System for Comorbid Anxiety Symptoms

Highlighting the FDA clearance announcement as a promising step in managing comorbid anxiety symptoms,...

August 18, 2021

FDA OKs Stimulation Device for Anxiety in Depression

Coverage of BrainsWay receiving FDA Clearance for the treatment of comorbid anxiety symptoms in adults...

August 18, 2021

BrainsWay clinches FDA nod for magnetic stimulation device to ease anxious depression

In-depth explanation as to how Deep TMS’s newest anxiety-depression clearance will help achieve BrainsWay’s...

August 16, 2021

Living with O.C.D. in a Pandemic

Highlights include treatment methods for OCD, emphasizing noninvasive techniques such as TMS as a valuable...